Camlin Fine Sciences Q1 FY27 Results: Revenue Rs 519 Cr, Net Loss Rs 35 Cr and Key Highlights

Camlin Fine Sciences Q1 FY27 results were announced on August 11, 2026, reporting a net loss of Rs 35 crore, widening from a loss of Rs 11 crore in Q1 FY26. Revenue from operations grew 22.74% year on year to Rs 519 crore from Rs 423 crore in Q1 FY26. The Camlin Fine Sciences Q1 FY27 results are on a consolidated basis for the quarter ended June 30, 2026.

Click Here – Get Free Investment Predictions

Camlin Fine Sciences Q1 FY27 Financial Highlights

The table below summarises the key financial metrics from the Camlin Fine Sciences Q1 FY27 results compared with the same quarter of the previous year (Q1 FY26).

Metric	Q1 FY27 (Jun 2026)	Q1 FY26 (Jun 2025)	YoY Change
Revenue from Operations (Rs Cr)	Rs 519 Cr	Rs 423 Cr	+22.74%
Gross Profit (Rs Cr)	Rs -9 Cr	Rs 2 Cr	-568.58%
Net Profit / (Loss) – PAT (Rs Cr)	Rs -35 Cr	Rs -11 Cr	-202.62%

Camlin Fine Sciences Q1 FY27 Performance Analysis

Use the Univest Screener to Track Live Fundamentals of Indian Stocks

Camlin fine sciences q1 fy27 results show revenue growth of 22.74% year on year to Rs 519 crore. Gross profit declined to Rs -9 crore from Rs 2 crore in Q1 FY26.

Net loss in the June 2026 quarter was Rs 35 crore, widening from a loss of Rs 11 crore in Q1 FY26. Investors tracking Camlin Fine Sciences quarterly results should verify these figures against the official BSE and NSE filings.

Key Business Factors in Camlin Fine Sciences Q1 FY27

1. Revenue Grew But Could Not Offset Losses

Revenue grew 22.74% year on year to Rs 519 crore. Despite the top-line trend, the company's Specialty Chemicals operations remain under pressure on the profitability front.

2. Operating Costs Compressed Gross Margins

Gross profit in the June 2026 quarter stood at Rs -9 crore, reflecting elevated cost burdens relative to revenue.

3. Net Loss Persists in Q1 FY27

The company reported a net loss of Rs 35 crore, widening from a loss of Rs 11 crore in Q1 FY26. A return to profitability will require either a meaningful revenue ramp-up or significant cost rationalisation across Specialty Chemicals operations.

Dividend Details

No dividend has been declared alongside the Camlin Fine Sciences quarterly results for the quarter ended June 2026. Investors may track future announcements via BSE India and NSE India portals.

Camlin Fine Sciences FY27 Outlook After Q1 Results

The June 2026 quarterly performance of Camlin Fine Sciences presents a mixed picture heading into the rest of FY27. Revenue recovery and cost rationalisation will be critical for the company to strengthen its financial position. Investors tracking Camlin Fine Sciences Q1 results should monitor management guidance, sector demand in Specialty Chemicals, and any strategic moves that could alter the earnings trajectory.

Camlin Fine Sciences Stock Performance

Download the Univest iOS App or Univest Android App to track Camlin Fine Sciences live share price and upcoming quarterly results.

Camlin Fine Sciences share price stood at Rs 126 on August 11, 2026, the day the quarterly results were declared. Post-results, the market will assess whether the Specialty Chemicals company's financial performance justifies the current valuation. Investors should verify the latest price and fundamentals on BSE and NSE before making any investment decision.

Key Risks to Watch After Camlin Fine Sciences Q1 FY27 Results

1. Sector-Specific Demand Headwinds

A slowdown in the Specialty Chemicals sector could weigh on Camlin Fine Sciences revenue and profitability beyond what the June 2026 quarter already reflects.

2. Input Cost and Margin Pressure

Rising raw material or operational costs could compress gross margins and limit net profit recovery in subsequent quarters of FY27.

3. Macroeconomic and Regulatory Uncertainty

Inflation, interest rate movements, and regulatory changes remain key risks to the earnings trajectory of Camlin Fine Sciences through FY27.

Conclusion

Camlin Fine Sciences Q1 FY27 results report revenue of Rs 519 crore and a net loss of Rs 35 crore, widening from a loss of Rs 11 crore in Q1 FY26. The June 2026 quarterly results highlight the ongoing challenges in the Specialty Chemicals space. Investors should review the full financial statements on BSE and NSE and consult a SEBI-registered advisor before any investment decision.

Frequently Asked Questions on Camlin Fine Sciences Q1 FY27 Results

When were the Camlin Fine Sciences Q1 FY27 results announced?

Ans. The June 2026 quarterly results for Camlin Fine Sciences were announced on August 11, 2026, covering the quarter ended June 30, 2026. The consolidated results were filed with BSE and NSE on the same date.

What is the PAT in the Camlin Fine Sciences Q1 FY27 results?

Ans. Net loss was Rs 35 crore in the June 2026 quarter, widening from a loss of Rs 11 crore in Q1 FY26.

What was the revenue in the Camlin Fine Sciences Q1 FY27 results?

Ans. Revenue for the June 2026 quarter rose 22.74% year on year to Rs 519 crore from Rs 423 crore in Q1 FY26.

Did Camlin Fine Sciences announce any dividend with the Q1 FY27 results?

Ans. No dividend has been declared alongside the June 2026 quarterly results. Investors may track future Camlin Fine Sciences dividend announcements through the BSE and NSE portals.

What is the Camlin Fine Sciences FY27 outlook after Q1 results?

Ans. The June 2026 quarterly performance signals a challenging start to FY27 for Camlin Fine Sciences. Key factors to watch include revenue trends, margin performance, and Specialty Chemicals sector demand through the rest of the financial year.

Is Camlin Fine Sciences a good buy after Q1 FY27 results?

Ans. The Q1 FY27 financial performance of Camlin Fine Sciences reflects challenging trends in the June 2026 quarter. This article is for educational purposes only and does not constitute investment advice. Please consult a SEBI-registered investment advisor.